Loading
PB
Peak Bio, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by LaMond Stephen J, was filed 28 Sept 2023.
Peak Bio, Inc.: what insiders have been doing
Every trade that managers of Peak Bio, Inc. disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Peak Bio, Inc. in twelve months, the latest record being from 4 December 2024.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
20
Thresholds
n/a
Buy Volume
€1,265
10 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 4 December 2024
Declarations20 total
83,800 shares0Common StockSEC:0000898432-24-000962:0
4,574,661 sharesCommon StockSEC:0000950170-24-128149:0
763,316 sharesCommon StockSEC:0000950170-24-128153:0
37,850 sharesCommon StockSEC:0000950170-24-128150:0
167,600 shares0Common StockSEC:0000898432-24-000203:0
11,750 sharesCommon StockSEC:0000950170-23-050434:0
Canonical exit: 14 Dec 2023 (T+90)
3,000 sharesCommon StockSEC:0000950170-23-050436:0
Canonical exit: 25 Dec 2023 (T+90)
45,000 sharesCommon StockSEC:0000950170-23-049688:0
Canonical exit: 20 Dec 2023 (T+90)
50,000 sharesCommon StockSEC:0000950170-23-049173:0
Canonical exit: 18 Dec 2023 (T+90)
25,000 sharesCommon StockSEC:0000950170-23-048771:0
Canonical exit: 14 Dec 2023 (T+90)
26,000 sharesCommon StockSEC:0000950170-23-048775:0
Canonical exit: 14 Dec 2023 (T+90)
30,000 sharesCommon StockSEC:0000950170-23-048367:0
Canonical exit: 12 Dec 2023 (T+90)
30,000 sharesCommon StockSEC:0000950170-23-047919:0
Canonical exit: 10 Dec 2023 (T+90)
00Common StockSEC:0000950170-23-047707:0
Canonical exit: 27 Nov 2023 (T+90)
5,500 shares@ US$0.250.1% of flowCommon StockSEC:0000950170-23-046053:0
Canonical exit: 27 Nov 2023 (T+90)
583,333 shares@ US$0.6034.3% of flowCommon StockSEC:0000950170-23-042830:0
458,333 shares@ US$0.6026.4% of flowCommon StockSEC:0000950170-23-033840:0
666,667 shares@ US$0.6039.1% of flowCommon StockSEC:0000899243-23-016550:0
1,437,500 shares0Common StockSEC:0000899243-22-035083:0
6,442,438 shares0Common StockSEC:0000899243-22-035081:0
20 of 20 declarations
About Peak Bio, Inc.
Peak Bio, Inc. is a company focused on developing innovative biological therapies. It aims to provide solutions for serious and unmet medical needs.
